2006The Chinese Journal of Modern Applied PharmacyRequires access

Therapeutic effect of reduced glutathione on systemic inflammatory response syndrome with severe trauma

Zhaojun Xu

Open publisher page 0 citations

Abstract

OBJECTIVE To observe the therapeutic value of the reduced glutathione(GSH) in critical illness cases with systemic inflammatory response syndrome(SIRS)after severe trauma.METHODS The 60 SIRS patients according to the diagnosis criteria of SIRS were randomly divided into regular treatment group(group B) and GSH treatment group(group A).The efficacy of the therapy in both groups were assessed and inflammatory cytokinases TNF-α,IL-6 and IL-10 levels were measured on admission in both of the groups. RESULTS SIRS markers all reduced more significantly in group A than that of in group B.The MODS incidence,TNF-α,IL-6 and IL-10 levels reduced more significantly in group A than that of in group B.CONCLUSION GSH improved significantly the clinical effects of SIRS, prohibited the inflammatory cytokinases and raised the anti-inflammatory cytokinases in the treatment of SIRS.

About this research paper

What this paper is about

OBJECTIVE To observe the therapeutic value of the reduced glutathione(GSH) in critical illness cases with systemic inflammatory response syndrome(SIRS)after severe trauma.METHODS The 60 SIRS patients according to the diagnosis criteria of SIRS were randomly divided into regular treatment group(group B) and GSH treatment group(group A).The efficacy of the therapy in both groups were assessed and inflammatory cytokinases TNF-α,IL-6 and IL-10 levels were measured on admission in both of the groups. RESULTS SIRS markers all reduced more significantly in group A than that of in group B.The MODS incidence,TNF-α,IL-6 and IL-10 levels reduced more significantly in group A than that of in group B.CONCLUSION GSH improved significantly the clinical effects of SIRS, prohibited the inflammatory cytokinases and raised the anti-inflammatory cytokinases in the treatment of SIRS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To observe the therapeutic value of the reduced glutathione(GSH) in critical illness cases with systemic inflammatory response syndrome(SIRS)after severe trauma.METHODS The 60 SIRS patients according to the diagnosis criteria of SIRS were randomly divided into regular treatment group(group B) and GSH treatment group(group A).The efficacy of the therapy in both groups were assessed and inflammatory cytokinases TNF-α,IL-6 and IL-10 levels were measured on admission in both of the groups. RESULTS SIRS markers all reduced more significantly in group A than that of in group B.The MODS incidence,TNF-α,IL-6 and IL-10 levels reduced more significantly in group A than that of in group B.CONCLUSION GSH improved significantly the clinical effects of SIRS, prohibited the inflammatory cytokinases and raised the anti-inflammatory cytokinases in the treatment of SIRS.

Key concepts: Systemic inflammatory response syndrome, Medicine, Inflammatory response, Glutathione, Gastroenterology, Internal medicine, Therapeutic effect, Group B

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic effect of reduced glutathione on systemic inflammatory response syndrome with severe trauma — Research Paper | ScholarLens